2024;150:Suppl_1: 4147448 5
Explore the possibility of starting with Wegovy or Zepbound, both of which offer robust support for weight loss today, while keeping an eye on Retatrutide's journey through the Retatrutide FDA approval process
GLP-1 Bridge is a workaround, since it operates outside the Part D benefit, runs on CMSs demonstration authority, and expires on December 31, 2027
When researchers at Stanford University compared the keto diet with the Mediterranean diet a more balanced approach that emphasizes whole grains, vegetables, lean proteins and healthy fatsboth were shown to improve blood sugar control, but there were important differences in sustainability
Semaglutide and other GLP-1 receptor agonists have transformed weight management, but patients planning pregnancy or currently pregnant often face critical questions about safety
(PubMed) Alanne M, Kristiansson K, Auro K, et al